BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karaman I, Kizilay-ozfidan G, Karadag CH, Ulugol A. Lack of effect of ceftriaxone, a GLT-1 transporter activator, on spatial memory in mice. Pharmacology Biochemistry and Behavior 2013;108:61-5. [DOI: 10.1016/j.pbb.2013.04.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Postnikova TY, Malkin SL, Zakharova MV, Smolensky IV, Zubareva OE, Zaitsev AV. Ceftriaxone Treatment Weakens Long-Term Synaptic Potentiation in the Hippocampus of Young Rats. Int J Mol Sci 2021;22:8417. [PMID: 34445137 DOI: 10.3390/ijms22168417] [Reference Citation Analysis]
2 Li HH, Lin PJ, Wang WH, Tseng LH, Tung H, Liu WY, Lin CL, Liu CH, Liao WC, Hung CS, Ho YJ. Treatment effects of the combination of ceftriaxone and valproic acid on neuronal and behavioural functions in a rat model of epilepsy. Exp Physiol 2021;106:1814-28. [PMID: 34086374 DOI: 10.1113/EP089624] [Reference Citation Analysis]
3 Smaga I, Fierro D, Mesa J, Filip M, Knackstedt LA. Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease. Neurosci Biobehav Rev 2020;115:116-30. [PMID: 32485268 DOI: 10.1016/j.neubiorev.2020.05.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
4 Valtcheva S, Venance L. Control of Long-Term Plasticity by Glutamate Transporters. Front Synaptic Neurosci 2019;11:10. [PMID: 31024287 DOI: 10.3389/fnsyn.2019.00010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
5 Mi DJ, Dixit S, Warner TA, Kennard JA, Scharf DA, Kessler ES, Moore LM, Consoli DC, Bown CW, Eugene AJ, Kang JQ, Harrison FE. Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP/PSEN1 mice. Neurobiol Aging 2018;71:241-54. [PMID: 30172223 DOI: 10.1016/j.neurobiolaging.2018.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
6 Roberts-Wolfe DJ, Kalivas PW. Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders. CNS Neurol Disord Drug Targets 2015;14:745-56. [PMID: 26022265 DOI: 10.2174/1871527314666150529144655] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 10.8] [Reference Citation Analysis]
7 Kim J, John J, Langford D, Walker E, Ward S, Rawls SM. Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice. Amino Acids 2016;48:689-96. [PMID: 26543027 DOI: 10.1007/s00726-015-2117-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
8 Oliveira JF, Sardinha VM, Guerra-gomes S, Araque A, Sousa N. Do stars govern our actions? Astrocyte involvement in rodent behavior. Trends in Neurosciences 2015;38:535-49. [DOI: 10.1016/j.tins.2015.07.006] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 14.3] [Reference Citation Analysis]
9 Soni N, Koushal P, Reddy B, Deshmukh R, Kumar P. Effect of GLT-1 modulator and P2X7 antagonists alone and in combination in the kindling model of epilepsy in rats. Epilepsy & Behavior 2015;48:4-14. [DOI: 10.1016/j.yebeh.2015.04.056] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
10 Freet CS, Lawrence AL. Ceftriaxone attenuates acquisition and facilitates extinction of cocaine-induced suppression of saccharin intake in C57BL/6J mice. Physiol Behav 2015;149:174-80. [PMID: 26066719 DOI: 10.1016/j.physbeh.2015.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Gunduz O, Topuz RD, Todurga ZG, Duvan K, Karadag CH, Ulugol A. Effect of Activation of the GLT-1 Transporter by a Beta-Lactam Antibiotic on Serotonin-Induced Scratching Behavior in Mice. Neurophysiology 2015;47:36-9. [DOI: 10.1007/s11062-015-9494-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Zumkehr J, Rodriguez-Ortiz CJ, Cheng D, Kieu Z, Wai T, Hawkins C, Kilian J, Lim SL, Medeiros R, Kitazawa M. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease. Neurobiol Aging 2015;36:2260-71. [PMID: 25964214 DOI: 10.1016/j.neurobiolaging.2015.04.005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 83] [Article Influence: 10.9] [Reference Citation Analysis]
13 Habibi-Asl B, Vaez H, Najafi M, Bidaghi A, Ghanbarzadeh S. Attenuation of morphine-induced dependence and tolerance by ceftriaxone and amitriptyline in mice. Acta Anaesthesiol Taiwan 2014;52:163-8. [PMID: 25557842 DOI: 10.1016/j.aat.2014.11.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
14 Soni N, Reddy BV, Kumar P. GLT-1 transporter: an effective pharmacological target for various neurological disorders. Pharmacol Biochem Behav 2014;127:70-81. [PMID: 25312503 DOI: 10.1016/j.pbb.2014.10.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
15 Matos-Ocasio F, Hernández-López A, Thompson KJ. Ceftriaxone, a GLT-1 transporter activator, disrupts hippocampal learning in rats. Pharmacol Biochem Behav 2014;122:118-21. [PMID: 24650590 DOI: 10.1016/j.pbb.2014.03.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]